medigraphic.com
SPANISH

Revista Mexicana de Urología

Organo Oficial de la Sociedad Mexicana de Urología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 2

<< Back Next >>

Rev Mex Urol 2020; 80 (2)

Intracavernous application of autologous bone marrow stem cells for medical treatment-refractory erectile dysfunction: A case report

Robles-Torres JI, Mancías-Guerra C, Garza-Bedolla A, Gómez-Guerra LS
Full text How to cite this article

Language: English
References: 12
Page: 1-9
PDF size: 362.16 Kb.


Key words:

Cell therapy, Erectile dysfunction, Stem cells.

ABSTRACT

Clinical case description: A 61-year-old man with severe erectile dysfunction related to diabetes mellitus of long duration was treated through intracavernous stem cell application. Transplantation of autologous bone marrow stem cells through a single intracavernous injection was performed. Clinical response, Doppler ultrasound of the penis, and adverse events were evaluated during the 50-week follow-up. The highest clinical response was reported at week 12, but it diminished thereafter. At the end of follow-up, ultrasound identified the presence of neovascularization emerging from the cavernous arteries.
Relevance: Numerous preclinical trials have demonstrated efficacy and safety, but there is insufficient clinical evidence showing promising results.
Clinical implications: No adverse events were detected, and ultrasound revealed hemodynamic changes that were possibly related to the therapy. The source and dosage of stem cells, as well as subsequent therapeutic applications, pose questions that remain to be answered.
Conclusions: Stem cell therapy for erectile dysfunction is a field of research that has sparked interest in numerous scientific groups, but clinical experience is still limited.


REFERENCES

  1. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000 Dec;12(6):305–11. doi: http://dx.doi.org/10.1038/sj.ijir.3900622

  2. Soebadi MA, Moris L, Castiglione F, Weyne E, Albersen M. Advances in stem cell research for the treatment of male sexual dysfunctions: Current Opinion in Urology. 2016 Mar;26(2):129–39. doi: http://dx.doi. org/10.1097/mou.0000000000000255

  3. Reed-Maldonado AB, Lue TF. The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review. World J Mens Health. 2016;34(3):155. doi: http://dx.doi. org/10.5534/wjmh.2016.34.3.155

  4. Alwaal A, Hussein AA, Lin C-S, Lue TF. Prospects of stem cell treatment in benign urological diseases. Korean J Urol. 2015;56(4):257. doi: http://dx.doi.org/10.4111/kju.2015.56.4.257

  5. Mayo Medical Laboratories. TTFB - Clinical: Testosterone, Total, Bioavailable, and Free, Serum. 2016. [accessed 2 Apr 2020] Available from: https://www.mayocliniclabs.com/testcatalog/ Clinical+and+Interpretive/83686

  6. Bahk JY, Jung JH, Han H, Min SK, Lee YS. Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases. Exp Clin Transplant. 2010;8(2):150–60.

  7. Yiou R, Hamidou L, Birebent B, Bitari D, Lecorvoisier P, Contremoulins I, et al. Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study. European Urology. 2016 Jun;69(6):988– 91. doi: http://dx.doi.org/10.1016/j. eururo.2015.09.026

  8. Levy JA, Marchand M, Iorio L, Cassini W, Zahalsky MP. Determining the Feasibility of Managing Erectile Dysfunction in Humans With Placental-Derived Stem Cells. J Am Osteopath Assoc. 2016 Jan 1;116(1):e1. doi: http://dx.doi. org/10.7556/jaoa.2016.007

  9. Haahr MK, Jensen CH, Toyserkani NM, Andersen DC, Damkier P, Sørensen JA, et al. Safety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial. EBioMedicine. 2016 Mar 1;5:204–10. doi: https://doi.org/10.1016/j.ebiom.2016.01.024

  10. Al Demour S, Jafar H, Adwan S, AlSharif A, Alhawari H, Alrabadi A, et al. Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical Trial. Urol Int. 2018;101(3):358–65. doi: http://dx.doi. org/10.1159/000492120

  11. Prieto D. Physiological regulation of penile arteries and veins. Int J Impot Res. 2008 Jan;20(1):17–29. doi: http://dx.doi. org/10.1038/sj.ijir.3901581

  12. Gómez-Guerra LS, Robles-Torres JI, Garza- Bedolla A, Mancías-Guerra C. Erectile dysfunction treated with intracavernous stem cells: A promising new therapy? Revista Internacional de Andrología. 2018 Jul;16(3):119–27. doi: http://dx.doi. org/10.1016/j.androl.2017.10.003




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Urol. 2020;80